Stocktoria
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 300760.SZ
CN · XSHE · XSHE · stock · Healthcare · website
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | CN¥33.3B | CN¥36.7B | CN¥34.9B | CN¥30.4B |
| Gross profit | CN¥20.1B | CN¥23.2B | CN¥22.4B | CN¥19.5B |
| R&D expense | CN¥3.6B | CN¥3.7B | CN¥3.4B | CN¥2.9B |
| SG&A expense | CN¥1.8B | CN¥1.7B | CN¥2.3B | CN¥2.0B |
| Operating income | CN¥9.9B | CN¥13.0B | CN¥12.9B | CN¥10.7B |
| Interest expense | CN¥24.0M | CN¥19.4M | CN¥13.0M | CN¥10.7M |
| Income tax | CN¥1.2B | CN¥1.3B | CN¥1.4B | CN¥1.3B |
| Net income | CN¥8.1B | CN¥11.7B | CN¥11.6B | CN¥9.6B |
| EPS (diluted) | CN¥6.71 | CN¥9.63 | CN¥9.56 | CN¥7.94 |
| Operating cash flow | CN¥10.1B | CN¥12.4B | CN¥11.1B | CN¥12.1B |
| Free cash flow | CN¥8.1B | CN¥10.5B | CN¥8.4B | CN¥10.2B |
| Cash & equivalents | CN¥17.7B | CN¥16.6B | CN¥18.8B | CN¥23.2B |
| Inventory | CN¥5.0B | CN¥4.8B | CN¥4.0B | CN¥4.0B |
| Total assets | CN¥59.3B | CN¥56.6B | CN¥47.9B | CN¥46.7B |
| Total liabilities | CN¥16.3B | CN¥15.9B | CN¥14.6B | CN¥14.7B |
| Shareholders' equity | CN¥38.1B | CN¥35.9B | CN¥33.1B | CN¥32.0B |
Growth · year-over-year · Revenue CAGR 3.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -9.4% | +5.1% | +15.0% | — |
| Net income growth | -30.3% | +0.7% | +20.6% | — |
| EPS growth | -30.3% | +0.8% | +20.4% | — |
| Free cash flow growth | -22.6% | +25.1% | -18.1% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · CN · as of 2025-12-31. Figures in CNY. Facts plus Stocktoria's own computed scores — not investment advice.